TheAlvesExperiment

I enjoy all things science and engineering whether at my job or in my personal life.

[TheAlvesExperiment @AlvesExperiment]

Having a great time at #IFoRE Sigma Xi conference discussing #convergence of diverse scientific communities to solve relevant and significant societal problems.

[TheAlvesExperiment @AlvesExperiment]

Come check out our recent publication in ChemMedChem looking at modulating enzyme activity leveraging multivalent inhibitors.

[ChemMedChem @ChemMedChem]

Multivalent Benzamidine Molecules for Plasmin Inhibition: Effect of Valency and Linker Length (Alves) @TanmayeNallan @AlvesExperiment #OpenAccess https://t.co/lufXDPbXsV

[ChemMedChem @ChemMedChem]

Multivalent Benzamidine Molecules for Plasmin Inhibition: Effect of Valency and Linker Length (Alves) @TanmayeNallan @AlvesExperiment #OpenAccess https://t.co/lufXDPbXsV

[BioCrossroads @BioCrossroads]

Love to see our #23Pair winners in the news! Thanks @InnovateIndiana for spotlighting the “next generation of life sciences leaders” affiliated with 𝗜𝗻𝗱𝗶𝗮𝗻𝗮 𝗨𝗻𝗶𝘃𝗲𝗿𝘀𝗶𝘁𝘆:
https://t.co/38gqWq0nBX

[IU Innovate Indiana @InnovateIndiana]

Six individuals affiliated with @IndianaUniv have been recognized as the "next generation of life sciences leaders" by @BioCrossroads. #23PAIR https://t.co/4siP7D6W8W

[TheAlvesExperiment @AlvesExperiment]

Had a great time @BioCrossroads at the event yesterday evening as an inaugural recipient of a #23Pair award. It is always nice to network and meet other champions for life science.

[TheAlvesExperiment @AlvesExperiment]

Currently in Chicago @THSNA_Societies giving a talk on a high fidelity ex-vivo blood clot formation and digestion model we developed as a clinical therapeutic testing platform. #THSNA2022

[BioCrossroads @BioCrossroads]

Nathan Alves holds 6 U.S. patents, has authored 41 peer-reviewed journal articles and is the 1st & only tenure track non-physician faculty member in @IUMedSchool's Dept of Emergency Medicine. @TaftLaw’s Gregory Coy says his #23Pair also mentors under-represented minorities.

[TheAlvesExperiment @AlvesExperiment]

@BioCrossroads @IUMedSchool @Taftlaw I am honored to be named a #23Pair recipient and look forward to continuing my translational work @IUSMEmergMed. Thank you @BioCrossroads for all you due to promote the advancement of Indiana Life Sciences.

[Amelia Linnemann, Ph.D. @LinnemannLab]

Happy to share our latest paper in @IsletsJournal, results of a fun collaboration with @AlvesExperiment, and led by @jjcrowde and Ziqian Zeng with critical contributions from @novak_alissa. Congrats to all!
https://t.co/5w1TnY3u7I

[TheAlvesExperiment @AlvesExperiment]

While the document is geared toward undergraduate URM students the process is applicable for anyone in any career at any stage and functions as a comprehensive decision tool.

[TheAlvesExperiment @AlvesExperiment]

If you struggle with establishing a career trajectory try this Future Life Mapping tool (see appendices for detailed instructions).

https://t.co/wy1ikgBCEf

[Dr. Glaucomflecken @DGlaucomflecken]

New CDC guidelines part 1

[Timothy Ellender, MD, FCCM @tjelle13]

⁦@IUSMEmergMed⁩

[TheAlvesExperiment @AlvesExperiment]

I am speaking at 2021 LSMRCE Virtual Conference: Empowering Diverse STEM Innovators. Please checkout the details of my talk at: https://t.co/dziuWAyUPv

[TheAlvesExperiment @AlvesExperiment]

https://t.co/VtxhR9rMBI

[TheAlvesExperiment @AlvesExperiment]

https://t.co/4ppP5BcK6G

[TheAlvesExperiment @AlvesExperiment]

Impressive study performed by some colleagues of mine that were primary contributors to the https://t.co/tH8SrlhYN7 consortium.

[Gabriel Bosslet @gbosslet]

HOLY CRAP I AM BEGGING PEOPLE AS AN ICU PHYSICIAN TO PLEASE PUT MASKS BACK ON AND STOP ACTING LIKE LIFE IS BACK TO NORMAL THIS IS WORSE THAN DECEMBER AND I DIDN’T THINK THAT WAS POSSIBLE

[U.S. FDA @FDA]

Today, FDA approved the first COVID-19 vaccine for the prevention of #COVID19 disease in individuals 16 years of age and older. https://t.co/iOqsxXV1fj